Page last updated: 2024-11-06

stercuronium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Stercuronium is a non-depolarizing neuromuscular blocking agent. It is a synthetic bisquaternary ammonium compound that is structurally related to pancuronium and atracurium. Stercuronium is used to provide muscle relaxation during surgery and mechanical ventilation. It works by blocking the transmission of nerve impulses to the muscles, resulting in paralysis. Stercuronium is typically administered intravenously and its effects are reversible. It is metabolized in the liver and excreted in the urine. Stercuronium is a potent neuromuscular blocking agent and it is typically used in conjunction with other medications, such as general anesthesia, to provide deep muscle relaxation.'

stercuronium: analog of conessine; RN given refers to iodide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID71925
CHEMBL ID3990238
MeSH IDM0044380

Synonyms (11)

Synonym
stercuronium
cona-4,6-dienin-3-aminium, n-ethyl-n,n-dimethyl-, (3.beta.)
unii-vmb91s0bdi
734477-69-1
vmb91s0bdi ,
stercuronium cation
cona-4,6-dienin-3-aminium, n-ethyl-n,n-dimethyl-, (3beta)
stercuronium ion
CHEMBL3990238
Q27291900
ethyl-dimethyl-[(1r,2s,5s,6s,9r,12s,13r,16s)-6,7,13-trimethyl-7-azapentacyclo[10.8.0.02,9.05,9.013,18]icosa-17,19-dien-16-yl]azanium
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]